Static Image
FDA Approves a New Oral Drug for Moderate to Severe RA

FDA Approves a New Oral Drug for Moderate to Severe RA

People with moderate to severe rheumatoid arthritis (RA) who haven’t responded well to one or more tumor necrosis factor (TNF) inhibitor medications now have a new option. The U.S. Food and Drug Administration (FDA) recently approved baricitinib (Olumiant), a pill that is taken once a day. Baricitinib is a targeted disease-modifying antirheumatic drug (DMARD) that blocks Janus kinase (JAK), a group of enzymes that enable inflammatory signals to be activated inside a cell. It’s the second in this class of drug to hit the market for the treatment of RA; tofacitinib (Xeljanz) was the first, approved in 2012. “It’s not a biologic ...more
Every Catch Deserves a Touchdown Dance

Every Catch Deserves a Touchdown Dance

Charcandrick West, professional football player with Louisiana roots, gets real about what keeps him going, how no hurdle is too high and why he likes to win on and off the field. Q1: When did you realize you wanted to play football professionally? I don’t remember the first moment I grasped a football, but the second I did, probably around age 6, I was hooked. I still remember being a kid, looking up from the field and seeing my mom and dad cheer me on. It was a thrill to know I was making people in the stands happy by giving the ...more
TAKE CARE: Advocacy Blog Series

TAKE CARE: Advocacy Blog Series

Premium Increases We’re excited to continue our advocacy blog series meant to help you take care when it comes to important arthritis health care and coverage issues. If you are just now tuning into this series, check out our previous blog posts on accumulator adjustment programs, pharmacist gag orders, President Trump’s drug pricing blueprint and drug rebates. This week we are focusing on the rise in premiums for health plans sold on the Affordable Care Act exchanges. Read on to learn more about how these increases may or may not impact your health insurance options. How do I know if I will be ...more
RA Research Briefs: Tofacitinib, Fish, Remission

RA Research Briefs: Tofacitinib, Fish, Remission

Keep up-to-date on the latest rheumatoid arthritis (RA) research with our brief research summaries. Tofacitinib Plus Methotrexate May Work As Well As Biologic If methotrexate (MTX) alone fails to control RA, adding the oral Janus kinase (JAX) inhibitor tofacitinib (Xeljanz) may be as effective as the standard practice of adding a biologic. The JAX inhibitor belongs to the third category of disease-modifying antirheumatic drugs (DMARDs) called targeted DMARDs. In a study of 1,146 patients with rheumatoid arthritis that had not adequately responded to MTX alone, approximately a third were switched to tofacitinib, while the others received either tofacitinib or the biologic adalimumab ...more
Study Ranks Treatments for Knee OA

Study Ranks Treatments for Knee OA

A new study takes a look at which approaches are best to bring relief to people with knee osteoarthritis (OA), a condition that affects approximately 20 percent of people over the age of 45 in the United States. Knee OA can be extremely painful and limit a person’s ability to function. Although there is no cure, numerous treatments are available to reduce symptoms, including over-the-counter and prescription drugs. Exercising and losing weight if a patient is overweight or obese also can help. Total knee replacement surgery is effective but is done only in cases where the disease is advanced and it’s ...more
Double Take: Twins with RA Fight It Together

Double Take: Twins with RA Fight It Together

Identical twins Annamarie and Ginamarie Russo share many qualities: They look and sound alike, they love acting and traveling – and both have rheumatoid arthritis (RA). For almost two decades, RA was one thing the twins, 31, did not share. Ginamarie was diagnosed with juvenile RA (now called juvenile idiopathic arth­ritis) when she was 12; Annamarie was diagnosed 18 years later, at age 30. “The pain started just after I turned 12,” says Ginamarie. She chalked it up to playing too much tennis, but the pain didn’t diminish. After seeing several doctors, she was finally diagnosed when she was almost 13. Although the ...more
Hyaluronic Acid for Osteoarthritis

Hyaluronic Acid for Osteoarthritis

If you have osteoarthritis (OA), you know all about joint pain and stiffness. One cause of these symptoms is the fact that hyaluronic acid (HA), a naturally occurring joint lubricant, breaks down in people with OA. To help alleviate the pain, your doctor might recommend treatment with hyaluronic acid injections – sometimes known as gel injections. What are HA injections? HA injections replace missing joint lubricant and are currently approved by the Food and Drug Administration (FDA) for use in the knees. However, some doctors may use the injections in shoulders and hips as well. The treatments will most likely take place in ...more
Voices: How Has a Loved One Supported You?

Voices: How Has a Loved One Supported You?

Three bloggers write about those who have given them strength and support in dealing with their health challenges. Carla Kienast  carlascorner.wordpress.com “I lean on the RA community” My husband has been my staunchest supporter – caring for me through nearly 20 surgeries since my diagnosis and supporting my decision to leave full-time employment due to my health, which was a huge decision. But the virtual and real friends I have made in the RA community see me through the day-to-day challenges of dealing with rheumatoid arthritis. Being able to connect and share with others who “get” what you’re going through is invaluable when ...more
Closing the Gap on the Nation’s Rheumatologist Shortage

Closing the Gap on the Nation’s Rheumatologist Shortage

Many of us know that access to care isn’t always a guarantee. All too often, seeing a rheumatologist includes traveling out of state because of the severe rheumatologist shortage. Last year we committed to closing this gap by offering Fellowship grants to universities in underserved areas. After careful consideration, we recently selected five schools to receive fellowship grants to help doctors advance in this specialty field. The institutions were offered $150,000 to launch new slots for established fellowship programs. We are thrilled to be able to offer these awards because of the impact the newly funded positions will have on their ...more
TAKE CARE: Advocacy Blog Series

TAKE CARE: Advocacy Blog Series

Drug Rebates  We’re excited to continue our advocacy blog series meant to help you take care when it comes to important arthritis health care and coverage issues. If you are just now tuning into this series, check out our previous blog posts on accumulator adjustment programs, pharmacist gag orders, and President Trump’s drug pricing blueprint. This week we dig in to the world of drug rebates, which are often negotiated between pharmaceutical manufacturers and pharmacy benefit managers (PBMs). Read on to learn more about how drug rebates play a role in the drug supply chain and impact access to medications. What are drug ...more